These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Changes in the antibacterial activity of chemotherapeutic agents (especially carbapenems) for 10 species of clinical isolates between 1994 and 1996. Surveillance group of the sensitivities of clinical isolates to antibacterial agents]. Igari J, Watanabe N, Uehara N, Inoue M, Yoshida H, Imafuku Y, Nishino T, Shibano T, Satou S, Kobayashi I, Takahashi A, Yomoda S, Matsuoka K, Oguri T, Ohba Y, Kumasaka K, Tokuda K, Kobayashi Y, Hongo T, Okada J, Sasaki T, Matsumoto N, Hirata Y, Nakasaki N, Ono J, Takata T, Kawaguchi R, Ohtaki Y, Kajimura K, Ishigo S, Hashimoto T, Aoki N, Okamoto E, Murakami E, Saeki H. Jpn J Antibiot; 2000 Mar; 53(3):157-70. PubMed ID: 10834147 [Abstract] [Full Text] [Related]
15. [Activity of cephems and carbapenems against clinically isolated Mycobacterium abscessus]. Ito K, Hashimoto K, Ogata H. Kekkaku; 2003 Sep; 78(9):587-90. PubMed ID: 14577345 [Abstract] [Full Text] [Related]
16. [Antimicrobial susceptibility of Pseudomonas aeruginosa isolated from urine at one hospital to mainly carbapenem and fluoroquinolone drugs]. Watanabe Y, Fujiue Y, Yano S, Shimizu S, Muroki K, Doi M, Kuwabara M. Jpn J Antibiot; 2006 Apr; 59(2):65-71. PubMed ID: 16805317 [Abstract] [Full Text] [Related]
19. Optimization of dose and dose regimen of biapenem based on pharmacokinetic and pharmacodynamic analysis. Takata T, Aizawa K, Shimizu A, Sakakibara S, Watabe H, Totsuka K. J Infect Chemother; 2004 Apr; 10(2):76-85. PubMed ID: 15160299 [Abstract] [Full Text] [Related]